SG59972A1 - Medicaments - Google Patents

Medicaments

Info

Publication number
SG59972A1
SG59972A1 SG1996007490A SG1996007490A SG59972A1 SG 59972 A1 SG59972 A1 SG 59972A1 SG 1996007490 A SG1996007490 A SG 1996007490A SG 1996007490 A SG1996007490 A SG 1996007490A SG 59972 A1 SG59972 A1 SG 59972A1
Authority
SG
Singapore
Prior art keywords
medicaments
pyridinedicarboyxlic
lacidipine
dimethylethoxy
arteriosclerosis
Prior art date
Application number
SG1996007490A
Other languages
English (en)
Inventor
Giovanni Gaviraghi
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of SG59972A1 publication Critical patent/SG59972A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SG1996007490A 1991-02-13 1992-02-08 Medicaments SG59972A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910359A IT1244728B (it) 1991-02-13 1991-02-13 Impiego medicamentoso di derivati diidropiridinici

Publications (1)

Publication Number Publication Date
SG59972A1 true SG59972A1 (en) 1999-02-22

Family

ID=11358541

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996007490A SG59972A1 (en) 1991-02-13 1992-02-08 Medicaments

Country Status (23)

Country Link
US (1) US5455257A (fr)
EP (2) EP0499920B1 (fr)
JP (1) JP2996725B2 (fr)
KR (1) KR100188171B1 (fr)
AT (1) ATE157004T1 (fr)
AU (1) AU646929B2 (fr)
CA (1) CA2103805C (fr)
CZ (1) CZ281760B6 (fr)
DE (1) DE69221649T2 (fr)
DK (1) DK0499920T3 (fr)
ES (1) ES2106098T3 (fr)
GR (1) GR3024661T3 (fr)
IE (1) IE920453A1 (fr)
IL (1) IL100928A (fr)
IT (1) IT1244728B (fr)
MX (1) MX9200600A (fr)
NO (1) NO303713B1 (fr)
PH (1) PH30130A (fr)
RU (1) RU2136279C1 (fr)
SG (1) SG59972A1 (fr)
UA (1) UA27780C2 (fr)
WO (1) WO1992014460A1 (fr)
ZA (1) ZA921006B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0809505T3 (da) * 1995-06-07 2003-07-07 Ivax Research Inc Anvendelse af pentosanpolysulfat til resolution af ar ved kroniske progressive vaskulære sygdomme
RU2287327C2 (ru) * 2003-10-16 2006-11-20 Юрий Антонович Кошелев Средство для лечения и профилактики атеросклероза
EP1868577A4 (fr) * 2005-04-15 2009-12-09 Reddys Lab Inc Dr Particules de lacidipine
WO2007096694A1 (fr) * 2006-02-22 2007-08-30 Ramiro Vergara Combinaison de principes actifs neuro-activateurs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597163A (ja) * 1982-07-02 1984-01-14 Yamanouchi Pharmaceut Co Ltd 抗動脈硬化剤
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
GB8431119D0 (en) * 1984-12-10 1985-01-16 Fujisawa Pharmaceutical Co Anti-arteriosclerotic composition

Also Published As

Publication number Publication date
US5455257A (en) 1995-10-03
EP0499920A1 (fr) 1992-08-26
DE69221649D1 (de) 1997-09-25
DK0499920T3 (da) 1998-01-26
MX9200600A (es) 1992-10-30
AU646929B2 (en) 1994-03-10
RU2136279C1 (ru) 1999-09-10
CZ165093A3 (en) 1994-03-16
JPH06505002A (ja) 1994-06-09
DE69221649T2 (de) 1997-12-11
ITMI910359A1 (it) 1992-08-13
ATE157004T1 (de) 1997-09-15
IT1244728B (it) 1994-08-08
ES2106098T3 (es) 1997-11-01
NO303713B1 (no) 1998-08-24
HK1009585A1 (en) 1999-06-04
IL100928A (en) 1997-02-18
CZ281760B6 (cs) 1997-01-15
PH30130A (en) 1997-01-21
CA2103805C (fr) 2002-09-17
ITMI910359A0 (it) 1991-02-13
IE920453A1 (en) 1992-08-12
NO932874D0 (no) 1993-08-12
NO932874L (no) 1993-08-12
CA2103805A1 (fr) 1992-08-14
ZA921006B (en) 1992-12-30
EP0499920B1 (fr) 1997-08-20
WO1992014460A1 (fr) 1992-09-03
UA27780C2 (uk) 2000-10-16
KR100188171B1 (en) 1999-06-01
EP0576433A1 (fr) 1994-01-05
GR3024661T3 (en) 1997-12-31
JP2996725B2 (ja) 2000-01-11
AU1223192A (en) 1992-09-15

Similar Documents

Publication Publication Date Title
NZ305166A (en) 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles; preparation and medicaments
IL116203A (en) Pharmaceutical compositions for the treatment of emesis comprising (2s, 3s) -3-(2-methoxybenzylamino)-2-phenylpiperidine and ondansetron
ATE121295T1 (de) Augentropfenarzneimittel.
CA2006267A1 (fr) Methode de traitement de l'herpes
FI903153A0 (fi) 11b-aryl-4-estrener, foerfarande foer deras framstaellning samt deras anvaendning som laekemedel.
IL87421A0 (en) Pharmaceutical compositions containing 5-amino(or substituted amino)-1,2,3-triazoles
IE880061L (en) 1,2,4,5-tetrasubstituted benzene derivatives
DE69300062D1 (de) Verfahren zur Herstellung von N-Methoxyderivate von 4-Hydroxy-2,2,6,6-Tetramethylpiperidin und 2,2,6,6-Tetramethyl-4-Piperidon.
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
AU1866888A (en) Pharmaceutical dosage unit containing 17beta-oestradiol and desogestrel
LV12251A (lv) 2-fenil-1,2-benzizoseleazol-3(2h)-ona pielietojums medikamenta razosanai kas paredzets alcheimera slimibas profilaksei un/vai terapijai
ZA921006B (en) Medicaments
IL88740A (en) Pharmaceutical compositions containing n-n-butyl deoxynojirimycin for treating aids
EE200000290A (et) Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks
RU93054780A (ru) Применение лацидипина для лечения артериосклероза
DE59310153D1 (de) Verfahren zur Herstellung von 4-Hydroxy-2.2.6.6-tetramethylpiperidin
NO920313D0 (no) Fremgangsmaate for fremstilling av rasemisk og optisk aktiv 1,2,3,4-tetrahydroisokinolin-3-karbonsyre samt forprodukter derav
ATE122352T1 (de) 3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen.
NO178093C (no) Anordning for bedring av miljö i munnhulen ved tannbehandling
NO960777D0 (no) Anvendelse av N-alkylerte 1,4-dihydropyridin dikarboksylsyreestere som medikamenter
IL89654A (en) Pharmaceutical combination compositions for treating hypertension
DE69616484D1 (de) Verwendung vom 3-Alpha-Hydroxy-5Alpha-Androsta-16-ene als Arzneimittel